Allurion Technologies PE Ratio 2021-2025 | ALUR
Current and historical p/e ratio for Allurion Technologies (ALUR) from 2021 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Allurion Technologies PE ratio as of June 11, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Allurion Technologies PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-11 | 2.71 | 0.00 | |
| 2025-03-31 | 3.21 | $-12.50 | 0.00 |
| 2024-12-31 | 10.75 | $-9.95 | 0.00 |
| 2024-09-30 | 15.33 | $-12.00 | 0.00 |
| 2024-06-30 | 24.95 | $-22.00 | 0.00 |
| 2024-03-31 | 43.75 | $-94.75 | 0.00 |
| 2023-12-31 | 93.50 | $-97.50 | 0.00 |
| 2023-09-30 | 107.50 | $-87.50 | 0.00 |
| 2023-06-30 | 266.75 | $-74.00 | 0.00 |
| 2023-03-31 | 256.00 | 0 | 0.00 |
| 2022-12-31 | 252.50 | 0 | 0.00 |
| 2022-09-30 | 246.75 | 0 | 0.00 |
| 2022-06-30 | 245.25 | 0 | 0.00 |
| 2022-03-31 | 244.50 | 0 | 0.00 |
| 2021-12-31 | 243.25 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.020B | $0.032B |
| Allurion Technologies Inc. is dedicated to ending obesity. The Allurion Program is a weight loss platform which combines the Allurion Gastric Balloon and only swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. Allurion Technologies Inc., formerly known as Compute Health Acquisition Corp., is based in NATICK, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.365B | 28.30 |
| Boston Scientific (BSX) | United States | $147.057B | 36.81 |
| Stryker (SYK) | United States | $145.454B | 30.41 |
| EssilorLuxottica (ESLOY) | France | $130.907B | 0.00 |
| Medtronic (MDT) | Ireland | $112.941B | 16.01 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.659B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.106B | 27.97 |
| ResMed (RMD) | United States | $36.856B | 27.68 |
| Agilent Technologies (A) | United States | $34.008B | 22.17 |
| GE HealthCare Technologies (GEHC) | United States | $33.609B | 15.96 |
| Terumo (TRUMY) | Japan | $26.946B | 35.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.201B | 15.96 |
| Insulet (PODD) | United States | $21.270B | 83.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.645B | 11.98 |
| Baxter (BAX) | United States | $16.114B | 12.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.196B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.264B | 21.80 |
| Lantheus Holdings (LNTH) | United States | $5.587B | 14.09 |
| Prestige Consumer Healthcare (PBH) | United States | $4.206B | 18.79 |
| Perrigo (PRGO) | Ireland | $3.763B | 9.54 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.435B | 15.65 |
| ICU Medical (ICUI) | United States | $3.309B | 24.40 |
| Envista Holdings (NVST) | United States | $3.259B | 27.08 |
| GN Store Nord (GNNDY) | Denmark | $2.362B | 19.57 |
| QuidelOrtho (QDEL) | United States | $2.094B | 14.40 |
| LeMaitre Vascular (LMAT) | United States | $1.878B | 41.99 |
| AtriCure (ATRC) | United States | $1.635B | 0.00 |
| Acuren (TIC) | United States | $1.305B | 0.00 |
| Neogen (NEOG) | United States | $1.238B | 15.85 |
| AdaptHealth (AHCO) | United States | $1.181B | 11.99 |
| BioLife Solutions (BLFS) | United States | $1.128B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.075B | 24.19 |
| Kestra Medical Technologies (KMTS) | United States | $1.001B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.989B | 12.64 |
| InMode (INMD) | Israel | $0.903B | 9.10 |
| Evolus (EOLS) | United States | $0.660B | 0.00 |
| CeriBell (CBLL) | United States | $0.642B | 0.00 |
| Owens & Minor (OMI) | United States | $0.606B | 5.03 |
| Capricor Therapeutics (CAPR) | United States | $0.600B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.581B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.554B | 0.00 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.429B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 13.21 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.340B | 60.40 |
| Canopy Growth (CGC) | Canada | $0.289B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.283B | 0.00 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.268B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.50 |
| ZimVie (ZIMV) | United States | $0.265B | 12.06 |
| Cresco Labs (CRLBF) | United States | $0.261B | 0.00 |
| Quanterix (QTRX) | United States | $0.259B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| Brainsway (BWAY) | Israel | $0.222B | 58.65 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| OraSure Technologies (OSUR) | United States | $0.218B | 0.00 |
| Omeros (OMER) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.199B | 0.00 |
| Organigram Global (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.09 |
| Verano Holdings (VRNOF) | United States | $0.183B | 0.00 |
| Exagen (XGN) | United States | $0.155B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.141B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.130B | 16.05 |
| Jin Medical (ZJYL) | China | $0.108B | 0.00 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Veru (VERU) | United States | $0.099B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.61 |
| TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.067B | 0.00 |
| Zynex (ZYXI) | United States | $0.062B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.21 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.014B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |